Enzon Announces Resignation of Chief Financial Officer

26-Apr-2005

Enzon Pharmaceuticals, Inc. announced that Kenneth J. Zuerblis, the Company's executive vice president and chief financial officer, has elected to resign from his position effective April 21, 2005, for personal reasons. The Company will promptly begin a search for his Replacement and Mr. Zuerblis will continue to serve in a consulting capacity for Enzon during the transition.

During Mr. Zuerblis' tenure Enzon has transitioned from a small royalty-based pharmaceutical company into one with significant revenues driven by five marketed products. Prior to joining Enzon, Mr. Zuerblis was employed as a senior manager by KPMG LLP, where he served in various advisory roles, including strategic business, tax, audit, and debt and equity financings.

Other news from the department people

Most read news

More news from our other portals

Discover the latest developments in battery technology!